Composition and method of valency controlled receptor systems for cell engineering and therapy
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsLei S. Qi, Paul B. Finn
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsLei S. Qi, Paul B. Finn
Estimating the term…
Provided herein are valency controllable receptor polypeptides configured to oligomerize upon recognition of a custom input. The receptors include an extramembrane signal recognition domain configured to recognize an extramembrane signal different from the custom input, a valency control module configured to recognize the custom input and induce oligomerization of the polypeptide, and an intramembrane signaling domain configured to modulate one or more intramembrane pathways. The provided receptors are particularly useful for engineered cell therapies. Also provided are systems and host cells including the disclosed receptors, and methods for using the disclosed materials.
A valency controllable receptor polypeptide comprising:
Dependencies are inferred from the claim text.